Cargando…

Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology

BACKGROUND: Blood adiponectin and leptin are adipokines that emerged as potential biomarkers for predicting Alzheimer’s disease (AD) owing to their strong connection with obesity. Although obesity affects the relation between beta-amyloid (Aβ) aggregation and cognitive decline, the longitudinal inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Keun You, Ha, Junghee, Kim, Minae, Cho, So Yeon, Kim, Hyunjeong, Kim, Eosu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635143/ https://www.ncbi.nlm.nih.gov/pubmed/36329496 http://dx.doi.org/10.1186/s13195-022-01107-3

Ejemplares similares

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status
por: Kim, Keun You, et al.
Publicado: (2022)

Association of metformin use with Alzheimer’s disease in patients with newly diagnosed type 2 diabetes: a population-based nested case–control study
por: Ha, Junghee, et al.
Publicado: (2021)

Adiponectin and Cognitive Decline
por: Rizzo, Maria Rosaria, et al.
Publicado: (2020)

Peripheral immune cell imbalance is associated with cortical beta-amyloid deposition and longitudinal cognitive decline
por: Mehta, Neel H., et al.
Publicado: (2023)

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers
por: Jang, Hyemin, et al.
Publicado: (2019)

The role of orexin in post-stroke inflammation, cognitive decline, and depression
por: Song, Juhyun, et al.
Publicado: (2015)

Association of cognitive enhancers and incident seizure risk in dementia: a population-based study
por: Ha, Junghee, et al.
Publicado: (2022)

Mild behavioral impairment linked to progression to Alzheimer’s disease and cortical thinning in amnestic mild cognitive impairment
por: Yoon, Eun Jin, et al.
Publicado: (2023)

Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment
por: Seo, Eun Hyun, et al.
Publicado: (2016)

The Effects of Longitudinal White Matter Hyperintensity Change on Cognitive Decline and Cortical Thinning over Three Years
por: Kim, Seung Joo, et al.
Publicado: (2020)

Amyloid‐β, cortical thickness, and subsequent cognitive decline in cognitively normal oldest‐old
por: Pelkmans, Wiesje, et al.
Publicado: (2021)

Cognitive decline according to amyloid uptake in patients with poststroke cognitive impairment
por: Yoon, Bora, et al.
Publicado: (2021)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
por: Li, QinJie, et al.
Publicado: (2022)

Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
por: van Bergen, J. M. G., et al.
Publicado: (2016)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Different Cortical Thinning Patterns Depending on Their Prognosis in Individuals with Subjective Cognitive Decline
por: Lim, Eun Ye, et al.
Publicado: (2019)

Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
por: Svenningsson, Anna Linnéa, et al.
Publicado: (2022)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

Pioglitazone use associated with reduced risk of the first attack of ischemic stroke in patients with newly onset type 2 diabetes: a nationwide nested case–control study
por: Ha, Junghee, et al.
Publicado: (2021)

Restless leg syndrome and risk of all-cause dementia: a nationwide retrospective cohort study
por: Kim, Keun You, et al.
Publicado: (2023)

Longitudinal associations between β-amyloid and cortical thickness in mild cognitive impairment
por: Mak, Elijah, et al.
Publicado: (2023)

Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography
por: Risacher, Shannon L., et al.
Publicado: (2017)

Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
por: Cole, James H., et al.
Publicado: (2017)

Beta amyloid deposition and cognitive decline in Parkinson’s disease: a study of the PPMI cohort
por: Mihaescu, Alexander S., et al.
Publicado: (2022)

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline
por: Ismail, Zahinoor, et al.
Publicado: (2021)

Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment
por: Liu, Shan, et al.
Publicado: (2019)

Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment
por: Liang, Chih-Sung, et al.
Publicado: (2021)

Cross-Sectional and Longitudinal Hippocampal Atrophy, Not Cortical Thinning, Occurs in Amyloid-Negative, p-Tau-Positive, Older Adults With Non-Amyloid Pathology and Mild Cognitive Impairment
por: Rane Levendovszky, Swati
Publicado: (2022)

Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline
por: Yun, Gyihyaon, et al.
Publicado: (2021)

Serum Adiponectin and In Vivo Brain Amyloid Deposition in Cognitively Normal Older Adults: A Cohort Study
por: Kim, Jee Wook, et al.
Publicado: (2023)

Distinctive Mediating Effects of Subcortical Structure Changes on the Relationships Between Amyloid or Vascular Changes and Cognitive Decline
por: Jung, Na-Yeon, et al.
Publicado: (2021)

The impact of education on cortical thickness in amyloid-negative subcortical vascular dementia: cognitive reserve hypothesis
por: Jung, Na-Yeon, et al.
Publicado: (2018)

The Effect of Clinical Characteristics and Subtypes on Amyloid Positivity in Patients with Amnestic Mild Cognitive Impairment
por: Kim, Jeong Yeon, et al.
Publicado: (2019)

Early Life Obesity Increases Neuroinflammation, Amyloid Beta Deposition, and Cognitive Decline in a Mouse Model of Alzheimer’s Disease
por: So, Simon W., et al.
Publicado: (2023)

Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals
por: d'Oleire Uquillas, Federico, et al.
Publicado: (2017)

Distinct effects of beta‐amyloid and tau on cortical thickness in cognitively healthy older adults
por: Harrison, Theresa M., et al.
Publicado: (2020)

The effect of statins on rate of cognitive decline in mild cognitive impairment
por: Smith, Kyle B., et al.
Publicado: (2017)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach
por: Kim, Jun Pyo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tfglt09ckhhcp6fplpu0vl8o3q